© 2022 MJH Life Sciences and Cannabis Patient Care. All rights reserved.
© 2022 MJH Life Sciences™ and Cannabis Patient Care. All rights reserved.
May 10, 2022
Dr. Woody, chief executive officer of 180 Life Sciences, discusses in this interview the current research surrounding synthetic cannabinoids as a treatment for chronic pain, as well as the development of a new type of medication that would have the potential to offer the benefits of cannabis without any undesirable effects.